PCA3 PREDICTS PROSTATE BIOPSY OUTCOME IN MEN RECEIVING DUTASTERIDE: RESULTS FROM THE DUTASTERIDE REDUCE TRIAL

被引：0
|
作者：
Andriole, Gerald
Aubin, Sheila
Reid, Jennifer
Sarno, Mark
Blase, Amy
Aussie, Jacqueline
Rittenhouse, Harry
Rittmaster, Roger
Groskopf, Jack
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词：
D O I：
10.1016/j.juro.2010.02.2109
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
2062
引用
收藏
页码：E801 / E801
页数：1
相关论文
共 50 条
  • [41] Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy
    Ochiai, Atsushi
    Okihara, Koji
    Kamoi, Kazumi
    Oikawa, Takehiro
    Shimazui, Toru
    Murayama, Shin-Ichiro
    Tomita, Kyoichi
    Umekawa, Tohru
    Uemura, Hirotsugu
    Miki, Tsuneharu
    BJU INTERNATIONAL, 2013, 111 (06) : 928 - 933
  • [42] Urinary PCA3 as a Predictor of Prostate Cancer in a Cohort of 3,073 Men Undergoing Initial Prostate Biopsy
    Chevli, K. Kent
    Duff, Michael
    Walter, Peter
    Yu, Changhong
    Capuder, Brian
    Elshafei, Ahmed
    Malczewski, Stephanie
    Kattan, Michael W.
    Jones, J. Stephen
    JOURNAL OF UROLOGY, 2014, 191 (06): : 1743 - 1748
  • [43] DUTASTERIDE IS ASSOCIATED WITH REDUCED RISK OF TRANSRECTAL PROSTATE BIOPSY-ASSOCIATED URINARY TRACT INFECTION AND RELATED HOSPITALIZATIONS: RESULTS FROM THE REDUCE STUDY
    Moreira, Daniel
    Andriole, Gerald
    Castro-Santamaria, Ramiro
    Freedland, Stephen
    JOURNAL OF UROLOGY, 2016, 195 (04): : E490 - E491
  • [44] Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers
    Ferro, Matteo
    Bruzzese, Dario
    Perdona, Sisto
    Mazzarella, Claudia
    Marino, Ada
    Sorrentino, Alessandra
    Di Carlo, Angelina
    Autorino, Riccardo
    Di Lorenzo, Giuseppe
    Buonerba, Carlo
    Altieri, Vincenzo
    Mariano, Angela
    Macchia, Vincenzo
    Terracciano, Daniela
    CLINICA CHIMICA ACTA, 2012, 413 (15-16) : 1274 - 1278
  • [45] UTILITY OF CAPDETECT™ PCA3 SCORE WITH OTHER FACTORS TO IMPROVE PREDICTION OF PROSTATE BIOPSY OUTCOME
    Amberson, James B.
    Blase, Amy
    Cochran, James S.
    Groskopf, Jack
    Harper, William M., IV
    Johnston, William G., Jr.
    Kella, Naveen
    Koziol, Isaac
    Patsias, Georgis
    Rabin, Mark
    Rittenhouse, Harry
    Williams, Thomas H.
    Weber, Art
    JOURNAL OF UROLOGY, 2009, 181 (04): : 812 - 812
  • [46] PREDICTING PROSTATE BIOPSY OUTCOME: PROSTATE HEALTH INDEX (PHI) AND PROSTATE CANCER ANTIGEN 3 (PCA3) ARE USEFUL BIOMARKERS
    Ferro, Matteo
    Montanaro, Vittorino
    Marsicano, Mariano
    Capece, Marco
    Terracciano, Daniela
    Sorrentino, Alessandra
    Marino, Ada
    Quarto, Giuseppe
    De Domenico, Renato
    Sorrentino, Domenico
    Altieri, Vincenzo
    Perdona, Sisto
    ANTICANCER RESEARCH, 2012, 32 (05) : 1940 - 1941
  • [47] Follow-up of men with an elevated PCA3 score and a negative biopsy: does an elevated PCA3 score indeed predict the presence of prostate cancer?
    Remzi, Mesut
    Haese, Alexander
    van Poppel, Hein
    de la Taille, Alexandre
    Stenzl, Arnulf
    Hennenlotter, Joerg
    Marberger, Michael
    BJU INTERNATIONAL, 2010, 106 (08) : 1138 - 1142
  • [48] DUTASTERIDE REDUCES THE RISK OF BIOPSY DETECTABLE PROSTATE CANCER AND BPH COMPLICATIONS AMONG MEN AT INCREASED PROSTATE CANCER RISK WITH CONCOMITANT BPH SUB ANALYSIS FROM THE REDUCE STUDY
    Marberger, Michael
    Montorsi, Francesco
    Tammela, Teuvo
    Andriole, Gerald
    Wilson, Timothy
    Fueyo Rodriguez, Arturo
    Castro, Ramiro
    JOURNAL OF MENS HEALTH, 2009, 6 (03) : 267 - 267
  • [49] DO METABOLIC COMORBIDITIES INFLUENCE THE ABILITY OF DUTASTERIDE TO LOWER PROSTATE CANCER RISK? RESULTS FROM THE REDUCE STUDY
    Freedland, Stephen
    Gerber, Leah
    Banez, Lionel L.
    McKeever, Madeline G.
    Moreira, Daniel M.
    Andriole, Gerald L.
    Rittmaster, Roger S.
    JOURNAL OF UROLOGY, 2011, 185 (04): : E483 - E483
  • [50] THE PCA3 ASSAY IMPROVES THE PREDICTION OF INITIAL BIOPSY OUTCOME AND MAY BE INDICATIVE OF PROSTATE CANCER AGGRESSIVENESS
    De La Taille, A.
    Graefen, M.
    De Reijke, T.
    Kil, P.
    Gontero, P.
    Mottaz, A.
    Irani, J.
    Haese, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 53 - 53
12345